Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Therapeutic protocols including EGFR antibodies in the context of oxaliplatin-based regimens have variable clinical effect in colorectal cancer. Here, we tested the effect of the EGFR antibody cetuximab in different sequential combinations with oxaliplatin on the growth of colorectal cancer cells in...

Descripción completa

Detalles Bibliográficos
Autores principales: Narvi, Elli, Vaparanta, Katri, Karrila, Anna, Chakroborty, Deepankar, Knuutila, Sakari, Pulliainen, Arto, Sundvall, Maria, Elenius, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224565/
https://www.ncbi.nlm.nih.gov/pubmed/30410004
http://dx.doi.org/10.1038/s41598-018-34938-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224565/
https://www.ncbi.nlm.nih.gov/pubmed/30410004
http://dx.doi.org/10.1038/s41598-018-34938-y

Ejemplares similares